|

AG-01 Compound Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • A&G Pharmaceutical Inc.1

Indications

  • Hormone-Resistant Breast Cancer1
  • Mesothelioma1
  • Triple Negative Breast Cancer1
  • Lung Cancer1
  • Breast Cancer1

Baltimore, Maryland1 trial

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

University of Maryland Greenebaum Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.